Clinical Trials
11
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials
Study to Evaluate the Efficacy and Safety of XC243 in Patients With Exacerbation of Chronic Cystitis
- Conditions
- Cystitis
- Interventions
- Drug: XC243 50 mgDrug: PlaceboDrug: XC243 25 mgDrug: XC243 75 mg
- First Posted Date
- 2024-04-30
- Last Posted Date
- 2024-04-30
- Lead Sponsor
- PHARMENTERPRISES LLC
- Target Recruit Count
- 280
- Registration Number
- NCT06391164
- Locations
- 🇷🇺
Unimed-S Cjsc, Moscow, Russian Federation
🇷🇺LLC "Research Center Eco-Safety", Saint Petersburg, Russian Federation
🇷🇺St. Petersburg State Budgetary Healthcare Institution "City Polyclinic № 112", Saint Petersburg, Russian Federation
Double-blind, Randomized, Placebo-controlled Study of the Safety, Tolerability and Pharmacokinetics of Ascending Doses of XC243 After Single and Multiple Oral Administration in Healthy Volunteers.
- Conditions
- Healthy Volunteers
- Interventions
- Drug: Placebo singleDrug: XC243 200 mg multipleDrug: XC243 100 mg singleDrug: XC243 200 mg single-dose food effectDrug: Placebo single-dose food effectDrug: Placebo multipleDrug: XC243 50 mg single
- First Posted Date
- 2022-11-28
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- PHARMENTERPRISES LLC
- Target Recruit Count
- 38
- Registration Number
- NCT05628116
- Locations
- 🇷🇺
LLS X7 Clinical Research, Saint Petersburg, Russian Federation
Study to Assess Efficacy and Safety of Treamid for Patients With Reduced Exercise Tolerance After COVID-19
- Conditions
- SARS-CoV-2 InfectionLung Fibrosis
- Interventions
- First Posted Date
- 2022-08-25
- Last Posted Date
- 2022-08-25
- Lead Sponsor
- PHARMENTERPRISES LLC
- Target Recruit Count
- 412
- Registration Number
- NCT05516550
Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 Pneumonia
- First Posted Date
- 2020-08-26
- Last Posted Date
- 2021-04-05
- Lead Sponsor
- PHARMENTERPRISES LLC
- Target Recruit Count
- 60
- Registration Number
- NCT04527354
- Locations
- 🇷🇺
Federal State-Funded Research Institution "Research Institute of Complex Cardiovascular Diseases", Kemerovo, Russian Federation
🇷🇺Federal State Budgetary Institution "N.N. Burdenko Military Clinical Hospital", Moscow, Russian Federation
🇷🇺SBEI HPE The First Moscow State Medical University n.a. Sechenov of Ministry of Health of Russian Federation, University Hospital #2, Department of Development of New Medicines, Moscow, Russian Federation
Study to Assess Safety, Tolerability and Pharmacokinetics of Treamid in Healthy Volunteers
- Conditions
- Metabolic Syndrome
- Interventions
- First Posted Date
- 2020-06-11
- Last Posted Date
- 2020-06-17
- Lead Sponsor
- PHARMENTERPRISES LLC
- Target Recruit Count
- 20
- Registration Number
- NCT04428593
- Prev
- 1
- 2
- 3
- Next